The combination of a serotonin reuptake inhibitor and Loxapine

Details for Australian Patent Application No. 2004269858 (hide)

Owner H. Lundbeck A/S

Inventors Willigers, Sandra Hogg; Cremers, Thomas Ivo Franciscus Hubert; Arnt, Jorn

Agent Watermark

Pub. Number AU-A-2004269858

PCT Pub. Number WO2005/023243

Priority PA 2003 01270 04.09.03 DK; 60/500,809 04.09.03 US

Filing date 1 September 2004

Wipo publication date 17 March 2005

International Classifications

A61K 31/343 (2006.01) - condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone

A61K 31/553 (2006.01) - having at least one nitrogen and at least one oxygen as ring hetero atoms, e.g. loxapine, staurosporine

A61P 25/22 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

Event Publications

23 March 2006 PCT application entered the National Phase

  PCT publication WO2005/023243 Priority application(s): WO2005/023243

19 June 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004269861-A method selecting an immunotherapeutic preparation

2004269857-The combination of a serotonin reuptake inhibitor and Amoxapine